S&P 500

5.222,68

0,16%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Zosano Pharma Corporation (ZSAN)
Zosano Pharma Corporation (ZSAN) Notícias

ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ZSAN

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
19/07/2022	12:48	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ZSAN	Zosano Pharma Corporation
07/06/2022	20:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
02/06/2022	09:36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
02/06/2022	09:00	GlobeNewswire Inc.	Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11	NASDAQ:ZSAN	Zosano Pharma Corporation
13/05/2022	17:17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
13/05/2022	17:00	GlobeNewswire Inc.	Zosano Pharma Reports First Quarter 2022 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
29/04/2022	17:02	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ZSAN	Zosano Pharma Corporation
29/04/2022	17:00	GlobeNewswire Inc.	Zosano Pharma Provides Corporate Update	NASDAQ:ZSAN	Zosano Pharma Corporation
11/04/2022	09:00	GlobeNewswire Inc.	Zosano Pharma Announces Reverse Stock Split Effective Today	NASDAQ:ZSAN	Zosano Pharma Corporation
01/04/2022	17:22	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ZSAN	Zosano Pharma Corporation
22/03/2022	08:46	TipRanks	Maxim Group Thinks Zosano Pharma’s Stock is Going to Recover	NASDAQ:ZSAN	Zosano Pharma Corporation
17/03/2022	17:05	GlobeNewswire Inc.	Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
14/02/2022	08:19	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ZSAN	Zosano Pharma Corporation
11/02/2022	19:31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ZSAN	Zosano Pharma Corporation
09/02/2022	19:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ZSAN	Zosano Pharma Corporation
08/02/2022	23:55	GlobeNewswire Inc.	Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants	NASDAQ:ZSAN	Zosano Pharma Corporation
08/02/2022	18:10	GlobeNewswire Inc.	Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants	NASDAQ:ZSAN	Zosano Pharma Corporation
05/01/2022	14:01	GlobeNewswire Inc.	CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose	NASDAQ:ZSAN	Zosano Pharma Corporation
05/01/2022	11:20	GlobeNewswire Inc.	Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose	NASDAQ:ZSAN	Zosano Pharma Corporation
13/12/2021	18:30	GlobeNewswire Inc.	Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang	NASDAQ:ZSAN	Zosano Pharma Corporation
29/11/2021	23:45	GlobeNewswire Inc.	Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ZSAN	Zosano Pharma Corporation
17/11/2021	10:00	GlobeNewswire Inc.	Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System	NASDAQ:ZSAN	Zosano Pharma Corporation
10/11/2021	18:10	GlobeNewswire Inc.	Zosano Pharma Reports Third Quarter 2021 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
04/10/2021	09:00	GlobeNewswire Inc.	Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results	NASDAQ:ZSAN	Zosano Pharma Corporation
02/09/2021	17:30	GlobeNewswire Inc.	Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
10/08/2021	17:05	GlobeNewswire Inc.	Zosano Pharma Reports Second Quarter 2021 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
20/07/2021	09:30	GlobeNewswire Inc.	Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Tr...	NASDAQ:ZSAN	Zosano Pharma Corporation
15/07/2021	07:30	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ZSAN	Zosano Pharma Corporation
02/07/2021	18:07	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ZSAN	Zosano Pharma Corporation
21/06/2021	17:09	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ZSAN	Zosano Pharma Corporation